Publication:
Apo E genotyping by restriction fragment length polymorphism in myocardial infarct survivors and healthy controls.

Simple item page
dc.contributor.authorsHergenc, G; Ilcol, Y; Budak, Y; Taga, Y
dc.date.accessioned2022-03-10T17:48:33Z
dc.date.accessioned2026-01-11T17:18:40Z
dc.date.available2022-03-10T17:48:33Z
dc.date.issued1999
dc.identifier.doidoiWOS:000083440300055
dc.identifier.issn0009-9147
dc.identifier.urihttps://hdl.handle.net/11424/220992
dc.identifier.wosWOS:000083440300055
dc.language.isoeng
dc.publisherAMER ASSOC CLINICAL CHEMISTRY
dc.relation.ispartofCLINICAL CHEMISTRY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleApo E genotyping by restriction fragment length polymorphism in myocardial infarct survivors and healthy controls.
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPage2050
oaire.citation.issue11
oaire.citation.startPage2050
oaire.citation.titleCLINICAL CHEMISTRY
oaire.citation.volume45

Files

Collections

Araştırma Çıktıları